Medical journal The Lancet on May 29 issued a correction to a recent study which found that antimalarial drugs Hydroxychloroquine and chloroquine were linked with an increased risk of mortality in hospitals, and an increased frequency of irregular heart rhythms. The study, titled, “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,” and published…
A massive study that raised health concerns over hydroxychloroquine, the anti-malaria drug touted by President TrumpDonald John TrumpMinneapolis erupts for third night, as protests spread, Trump vows retaliation Stocks open mixed ahead of Trump briefing on China The island that can save America MORE as a coronavirus treatment, is coming under scrutiny from scientists who…
The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed at the Rock Canyon Pharmacy in Provo, Utah, May 27, 2020.George Frey | ReutersU.S. prescriptions for malaria drug hydroxychloroquine surged nearly 2,000% in March when President Donald…
The move comes after the World Health Organization halted clinical trials of the drug as a treatment, citing a study that found no benefit and a higher mortality rate for hospitalized patients. A box of hydroxychloroquine, under the brand name Plaquenil, is seen in a pharmacy in Paris. Chesnot/Getty Images hide caption toggle caption Chesnot/Getty…
WHO has praised China for its eagerness towards the prospect of scientific inquiries into determining the origins of COVID-19. The number of coronavirus cases in Russia has climbed to 353,427, with 8,946 new infections in the past 24 hours. The United States has barred arrivals from Brazil, the country with the second-highest number of cases in the…
Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : 6e45a2ae-9876-47e1-a8c3-bd4a119f
You don't have permission to access "http://www.medpagetoday.com/hematologyoncology/othercancers/117844" on this server. Reference #18.4cd7ce17.1759928511.c4fd9446 https://errors.edgesuite.net/18.4cd7ce17.1759928511.c4fd9446
TURLOCK, Calif. — California, like much of the nation, is not producing enough nurses working at bedsides to meet the needs of an aging and diverse population, fueling a workforce crunch that risks endangering quality patient care. Nearly 60% of California counties, stretching between the borders with Mexico and Oregon, face a nursing shortage, according